Antiviral cytotoxic responses of primate gamma delta T cells isolated by magnetic cell separation. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Antiviral cytotoxic responses of primate gamma delta T cells isolated by magnetic cell separation.

Symp Nonhum Primate Models AIDS. 1993 Sep 19-22;11:abstract no. 26. Unique Identifier : AIDSLINE PRIM11/94191619
Wallace M; Pauza CD; Malkovsky M; Dept. of Medical Microbiology and Immunology, Univ. of Wisconsin; at Madison.


Abstract: We have previously reported that certain human or rhesus monkey gamma delta T cell clones lyse lymphoid cells infected with immunodeficiency viruses (Malkovsky et al., J. Med. Primatol. 21:113, 1992). The same uninfected lymphoid cells are not lysed. This observation and the report that elevated numbers of gamma delta T cells have been observed in HIV-1 infected individuals (De Paoli et al., Clin. Exp. Immunol. 83:187, 1991) suggest a role for this T lymphocyte subset in AIDS. During our experience in culturing these cells, we have observed increases in both the percentage and absolute number of gamma delta T cells in peripheral blood mononuclear cell populations from both humans and rhesus monkeys cultured in medium with IL-2. As an alternative to gamma delta T cell cloning, we have isolated gamma delta T cells from these cultures using positive selection by monoclonal antibodies and magnetic beads. The functional responses of these cells and gamma delta T cell clones were compared. Initial experiments examining cytotoxic responses of human gamma delta T cells isolated by this method indicate that these gamma delta T cell lines exhibit selective cytotoxicity for immunodeficiency virus-infected cells as do some gamma delta T cell clones. With this method, we may be able to assess the potential antiviral response of the gamma delta T cell population present in immunodeficiency virus-infected primates without the lengthy and laborious procedure of generating gamma delta T cell clones.
Keywords: Acquired Immunodeficiency Syndrome/*IMMUNOLOGY Animal Cell Separation/METHODS Cells, Cultured Clone Cells *Cytotoxicity, Immunologic Human Macaca mulatta Magnetics Primates Receptors, Antigen, T-Cell, gamma-delta/*ANALYSIS T-Lymphocyte Subsets/CYTOLOGY/*IMMUNOLOGY ABSTRACTKWDacquiredimmunodeficiencysyndrome/KWDimmunologyanimalcellseparation/methodscells,culturedclonecellsKWDcytotoxicity,immunologichumanmacacamulattamagneticsprimatesreceptors,antigen,t-cell,gamma-delta/KWDanalysist-lymphocytesubsets/cytology/KWDimmunologyabstract
940730
M9470899

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .